Discover 2,716 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,716
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
for
Neoplasm Malignant
Location: New Brunswick NJ, Montreal, Baltimore MD, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07209111
Phase2, Recruiting
Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder
for
Bipolar Disorder (BD), Psychosis
Location: Hamilton
Sponsor: McMaster University
Sex: All
Age: 18 - 35
Code: NCT07213492
Recruiting
Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients
for
Burn Scar, Burn Wound
Location: Hamilton, Edmonton
Sponsor: Birch BioMed Inc
Sex: All
Age: 12 - 65
Code: NCT06807021
Phase2, Phase3, Recruiting
Interaction Between Dairy and Gut Hormone Response on Cognitive Performance in Children.
for
Children, Healthy
Location: Toronto
Sponsor: Toronto Metropolitan University
Sex: All
Age: 9 - 14
Code: NCT07231146
Recruiting
An Evaluation of Dose-escalation for Intrathoracic Tumours
for
Lung Cancers
Location: Waterloo, London, Kelowna
Sponsor: Chris Goodman
Sex: All
Age: 18+
Code: NCT06794125
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial
for
Tobacco Use Disorder, Psychiatric Disorder, Nicotine Dependence
Location: Toronto
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 18 - 70
Code: NCT06534047
Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
for
Chronic Spontaneous Urticaria
Location: Quebec, White Marsh MD, Ottawa, Niagara Falls,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07219615
Phase2, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase3, Recruiting
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
for
Hepatitis B Virus (HBV), Lung Transplant Recipient
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Montreal, Washington D.C. DC, Toronto, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT04901702
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Quebec, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase3, Recruiting
Suitability of the 26 °C Indoor Temperature Upper Limit for Older Adults: Impacts of Clothing and Daily Activity
for
Heat Stress, Physiological Stress
Location: Ottawa
Sponsor: University of Ottawa
Sex: All
Age: 65 - 70+
Code: NCT07189507
Recruiting
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor